top of page
Copy of Finger-Prick Test Developed For ‘Trich’ A Common, Undiagnosed STI
https://scienceblog.com/537081/finger-prick-test-developed-for-trich-a-common-undiagnosed-sti/ A quick, affordable diagnostic test...
MedMira
29. März 20232 Min. Lesezeit
MedMira receives 3 new trademarks
MedMira has been notified that the Company has successfully defended its claim on its submitted trademarks. VYRA U.S. Serial Number:...
MedMira
24. März 20231 Min. Lesezeit
Copy of Update on MedMira’s Reveal® TP (Syphilis) Clinical Trials in Canada
Halifax, Nova Scotia, 14 March, 2023 – Today, MedMira Inc. (MedMira) (TSXV: MIR) provides an update on its progress to achieve regulatory...
MedMira
14. März 20233 Min. Lesezeit
Copy of MedMira enters into Partnership with Maternova for USA and Latin America
Halifax, Nova Scotia, 20 Februrary, 2023 – Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the singing of a multinational...
MedMira
20. Feb. 20233 Min. Lesezeit
Public Information
The Company planned to issue a Press Release with a commercial update this month. Due to a highly positive change in the commercial...
MedMira
31. Jan. 20231 Min. Lesezeit
MedMira receives CE mark for its VYRA™ CoV2Flu Antigen Test
Halifax, Nova Scotia, 11 January, 2023 – Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the receipt of the CE mark for its VYRA™...
MedMira
11. Jan. 20233 Min. Lesezeit
bottom of page